Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Achaogen Inc    AKAO

ACHAOGEN INC (AKAO)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2018 04/16/2018 04/17/2018 04/18/2018 04/19/2018 Date
12.39(c) 12.21(c) 12.34(c) 12.68(c) 13.01(c) Last
1 542 226 999 540 827 164 1 489 833 1 471 430 Volume
+5.72% -1.45% +1.06% +2.76% +2.60% Change
More quotes
Financials (USD)
Sales 2018 12,7 M
EBIT 2018 -169 M
Net income 2018 -164 M
Finance 2018 50,2 M
Yield 2018 -
Sales 2019 62,3 M
EBIT 2019 -111 M
Net income 2019 -111 M
Debt 2019 36,7 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 40,8x
EV / Sales2019 9,69x
Capitalization 567 M
More Financials
Company
Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections.It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood... 
More about the company
Surperformance© ratings of Achaogen Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACHAOGEN INC
04/16ACHAOGEN : Health and Human Services Department (HHS); Food and Drug Administrat..
AQ
04/13ACHAOGEN : Announces Multiple Plazomicin Presentations at European Congress of C..
AQ
04/10Achaogen Announces Multiple Plazomicin Presentations at European Congress of ..
GL
04/09ACHAOGEN : Health and Human Services Department (HHS); Food and Drug Administrat..
AQ
04/02ACHAOGEN : Health and Human Services Department (HHS); Food and Drug Administrat..
AQ
03/27ACHAOGEN : Announces New Employment Inducement Grants
AQ
03/26ACHAOGEN : Health and Human Services Department (HHS); Food and Drug Administrat..
AQ
03/26ACHAOGEN : Announces Date of FDA Advisory Committee Meeting for Plazomicin
AQ
03/22Achaogen Announces New Employment Inducement Grants
GL
03/21Achaogen Announces Date of FDA Advisory Committee Meeting for Plazomicin
GL
More news
Sector news : Bio Therapeutic Drugs
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Bio Therapeutic Drugs
Latest Tweets
04/19Achaogen $AKAO Expected to Post Q1 2018 Earnings of -$0.85 Per Share  
04/18$NBRV $AKAO we need these companies to succeed.. Important indications.. 
04/18$AKAO nHOD this hour vol same as last hour, so no let up
1
04/18$AKAO D1 inside up, M30 inside up - this one is coiled
1
04/18Leerink Swann Raises Achaogen Q1 2018 Earnings Estimates to ($0.85) EPS (Prev..
1
More tweets
Qtime:60
News from SeekingAlpha
04/16BIOTECH FORUM : The Week Ahead 
04/15SPECIALTY REPORT ON INFECTIOUS DISEA : Unlocking The Upcoming Binary Event Of Ac.. 
04/13Key events next week - healthcare 
04/08DAILY INSIDER RATINGS ROUND UP 4/4/1 : Akao, ddr, iff, opk 
03/31DAILY INSIDER RATINGS ROUND UP 3/30/ : Akao, dss, mmac 
Chart ACHAOGEN INC
Duration : Period :
Achaogen Inc Technical Analysis Chart | AKAO | US0044491043 | 4-Traders
Technical analysis trends ACHAOGEN INC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 21,6 $
Spread / Average Target 66%
EPS Revisions
Managers
NameTitle
Blake Wise Chief Executive Officer & Director
Kenneth J. Hillan President, Director, Head-Research & Development
Bryan E. Roberts Chairman
Tobin Schilke CFO & Principal Accounting Officer
Lee Swem Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
ACHAOGEN INC18.06%567
GILEAD SCIENCES5.35%98 675
VERTEX PHARMACEUTICALS10.10%41 476
REGENERON PHARMACEUTICALS-14.19%34 613
GENMAB22.84%12 833
BEIGENE LTD (ADR)73.08%9 059